drugset / Trial / NCT01836276

Understanding Disparities in Quitting in African American and White Smokers

NCT01836276

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.

Timeline

Start
2013-02
Primary completion
2017-04
Completion
2017-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg

Indications

No indication recorded.